About Department of Clinical and Experimental Medicine, University of Pisa
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Horizon Pharma USA, Inc.
2
University of Pisa
2
Clinical Trials at Department of Clinical and Experimental Medicine, University of Pisa
During the past decade, Department of Clinical and Experimental Medicine, University of Pisa conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Study of VEGFR-2 /IL-8 Genetic Interaction in MBC Treated With Paclitaxel and Bevacizumab vs. Chemotherapy
2014-04-01
2018-07-01
Unknown status
189
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study
2017-10-04
2020-11-30
Completed
83
Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study
2018-04-16
2021-02-17
Completed
51
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Department of Clinical and Experimental Medicine, University of Pisa
According to Clinical.Site data, the most researched conditions in "Department of Clinical and Experimental Medicine, University of Pisa" are
"Metastatic Breast Cancer" (2 trials), "Thyroid Eye Disease" (2 trials) and "Graves' Orbitopathy" (1 trials). Many other conditions were trialed in "Department of Clinical and Experimental Medicine, University of Pisa" in a lesser frequency.
Clinical Trials Intervention Types at Department of Clinical and Experimental Medicine, University of Pisa
Most popular intervention types in "Department of Clinical and Experimental Medicine, University of Pisa" are "Biological" (2 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Teprotumumab" (2 trials), "Placebo" (1 trials) and "genetic interaction analysis" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Department of Clinical and Experimental Medicine, University of Pisa
The vast majority of trials in "Department of Clinical and Experimental Medicine, University of Pisa" are
2 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Department of Clinical and Experimental Medicine, University of Pisa
Currently, there are NaN active trials in "Department of Clinical and Experimental Medicine, University of Pisa".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Department of Clinical and Experimental Medicine, University of Pisa,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Department of Clinical and Experimental Medicine, University of Pisa, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".